ILMN
Illumina Inc
NASDAQ: ILMN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$126.74
+5.29% today
Updated 2026-04-30
Market cap
$18.29B
P/E ratio
22.09
P/S ratio
4.21x
EPS (TTM)
$5.45
Dividend yield
—
52W range
$74 – $156
Volume
1.6M
WallStSmart proprietary scores
64
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B5.3
Quality
C+8.5
Profitability
A6.7
Valuation
B5/9
Piotroski F-Score
Moderate
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$136.67
+7.83%
12-Month target
$127.31
+0.45%
Intrinsic (DCF)
$294.98
Margin of safety
+60.55%
1 Strong Buy8 Buy7 Hold1 Sell2 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 33.40% — strong efficiency
+ Free cash flow $267.00M — positive
+ 60.55% below intrinsic value
Risks
- Altman Z 1.62 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $4.58B | $4.50B | $4.37B | $4.34B | $4.34B | $4.6B |
| Net income | $-4.40B | $-1.16B | $-1.22B | $850.00M | $334.00M | — |
| EPS | — | — | — | — | $5.45 | $5.12 |
| Free cash flow | $106.00M | $283.00M | $709.00M | $931.00M | $267.00M | — |
| Profit margin | -96.07% | -25.78% | -27.97% | 19.58% | 19.60% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | ULLEM, SCOTT B. | Buy | 190 | $131.55 |
| 2026-03-31 | MEISTER, KEITH A. | Buy | 161 | $131.55 |
| 2026-03-05 | WEDEL, CHRISTENSEN JAKOB | Buy | 6,551 | $128.24 |
Peer comparison
Smart narrative
Illumina Inc trades at $126.74. representing a P/E of 22.09x trailing earnings. Our Smart Value Score of 64/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.62, it sits in the distress. TTM revenue stands at $4.34B. with profit margins at 19.60%. Our DCF model estimates intrinsic value at $294.98.
Frequently asked questions
What is Illumina Inc's stock price?
Illumina Inc (ILMN) trades at $126.74.
Is Illumina Inc overvalued?
Smart Value Score 64/100 (Grade C+, Hold). DCF value $294.98.
What is the price target of Illumina Inc (ILMN)?
The analyst target price is $136.67, representing +7.8% upside from the current price of $126.74.
What is the intrinsic value of Illumina Inc (ILMN)?
Based on our DCF model, intrinsic value is $294.98, a +60.5% margin of safety versus $126.74.
What is the future stock price of ILMN by 2030?
Our research-backed model estimates Illumina Inc could reach $536.51 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Illumina Inc's revenue?
TTM revenue is $4.34B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.62 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.21x
ROE33.40%
Beta1.49
50D MA$125.40
200D MA$117.70
Shares out0.15B
Float0.15B
Short ratio—
Avg volume1.6M
Performance
1 week-5.87%
1 month-4.94%
3 months-16.88%
YTD-8.23%
1 year—
3 years—
5 years—